In one of the first major medtech acquisitions of 2021, Steris (NYSE:STE) announced in January that it was set to buy Cantel Medical (NYSE:CMD).
The acquisition combines Steris’ offerings of sterilizers and washers with Cantel’s devices that center around endoscope disinfection, water purification and filtration for dialysis along with healthcare disposables. The companies said the deal adds a full suite of high-level disinfection disposables, capital equipment and services and additional single-use accessories to Steris’s endoscopy offerings. Cantel’s dental business will also extend Steris into a new segment of potential customers.
“We have long appreciated Cantel, which is a natural complement and extension to Steris’s product and service offerings, global reach and customers,” Steris CEO Walt Rosebrough said. “Our companies share a similar focus on infection prevention across a range of healthcare customers. Combined, we will offer a broader set of customers a more diversified selection of infection prevention and procedural products and services.”